Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Neuroepithelial

Explore clinical trials studying Neoplasms, Neuroepithelial. Study availability and eligibility vary by location and protocol.

2,951 public trials 642 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Neuroepithelial trial results

Active, Not Recruiting

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

NCT02359565

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +46 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View Trial Details
Active, Not Recruiting

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

NCT06413706

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
Locations
  • Children's Hospital of Orange County - Orange Orange, California, United States
  • Lucile Packard Children's Hospital (LPCH) - Stanford University Palo Alto, California, United States
  • Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States
  • The Johns Hopkins Hospital (JHH) - Johns Hopkins Childrens Center Baltimore, Maryland, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.

NCT05109728

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • Col Uni Med Center New York Presby New York, United States
  • University of Pittsburgh Pittsburgh, Pennsylvania, United States
  • MD Anderson Cancer Center Uni of Te Houston, Texas, United States
  • University of Wisconsin School of Medicine and Public Health Madison, Wisconsin, United States
View all 14 locations
View Trial Details
Active, Not Recruiting

A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

NCT03423628

Conditions
Astrocytoma, Behavior, Brain Diseases, +31 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site New York, United States
  • Research Site Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma

NCT03115333

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Eden Hospital Medical Center Castro Valley, California, United States
View all 58 locations
View Trial Details
Active, Not Recruiting

Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations

NCT03581292

Conditions
Anaplastic Astrocytoma, Astrocytoma, Glioblastoma, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 163 locations
View Trial Details
Active, Not Recruiting

Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

NCT02724579

Conditions
Glioma, Medulloblastoma, Neoplasms, +7 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
View all 195 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma

NCT02704858

Conditions
Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Sutter Health Research Institute San Francisco, California, United States
  • Saint John Cancer Institute Santa Monica, California, United States
  • Georgia Cancer Center (Augusta University) Augusta, Georgia, United States
View Trial Details
Active, Not Recruiting

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

NCT04284774

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine Gland Neoplasms, Endocrine System Diseases, +102 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 172 locations
View Trial Details

Related conditions